Lutetium PSMA Therapy Cost in India

Lutetium-177 is a radioactive material that emits beta radiation, which is a type of radiation that is harmful to living things. Lutetium-177 is attached to a short peptide that binds to the PSMA receptor on the surface of cancer cells. When the Lutetium 177 - PSMA complex is coupled to a prostate cancer cell, it produces lethal radiation, causing the cancer cell to die. The surrounding normal cells are spared due to the low penetration of the released beta particle.

Lu177 PSMA is injected into the vein. The patient is admitted to the hospital and will be there for the next 24 hours. Prior to the Lu177 PSMA injection, a MAG3/EC scan is performed to assess kidney function.

Intravenous fluids are normally given to the patient before and after the Lu177 PSMA is given throughout a 24-hour period.

PSMA Lu177 is well tolerated. A little dry mouth, tiredness, and nausea are the most prevalent adverse effects. About 2-3 weeks following the Lu177 PSMA delivery, there may be a modest drop in white blood cells and platelets. These side effects are usually mild and transitory, and they go away on their own without any active therapy. Serious or life-threatening consequences are relatively uncommon.

Lu177 PSMA response rates are determined by the tumor biology of prostate cancer, the initial Gleason Score, the degree of illness, and prior therapy responses. Lu177 PSMA therapy typically results in a drop in S. PSA and a shrinking of tumors in more than 70% of patients. By the second dosage of therapy, nearly all patients have experienced a reduction in pain and an improvement in overall health.

Lu PSMA Therapy is a particularly precise therapy that is used to treat metastatic prostate cancer or when other methods of treatment are no longer effective. Patients with advanced castration-resistant metastatic prostate cancer who have shown indications of tumor progression are candidates for this treatment. The following symptoms may appear as cancer progresses:

• Rising Serum PSA levels
• Increase in the size or number of the metastatic lesions on CT/MRI or Ga68 PSMA scans
• Increasing pain or other worsening symptoms due to the disease
• Lu177 PSMA Therapy cannot be given to patients in case of Severe renal insufficiency
• Severe hematological compromise

Apart from the lutetium PSMA therapy cost in India, there are additional expenses to consider when planning your trip. This includes budgeting for meals, airfare costs which will vary depending on your location of origin and the time of booking, and ground transportation expenses, such as taxi fares or rental car costs. Lastly, accommodation costs during your recovery period are crucial to consider, whether you opt for a hotel near the medical facility or other lodging options that suit your preferences and budget.

By carefully considering these additional expenses alongside lutetium PSMA therapy cost in India, you can better plan and budget for your medical trip to India, ensuring a smooth and comfortable experience during your recovery process.